Table 3 Comparisons of demographic data and clinical features of patients of RL-LDLT who underwent RYHJ
Demographic and clinical features | Success group (n = 15) | Restenosis group (n = 4) | p |
|---|---|---|---|
Median (IQR) | Median (IQR) | ||
Recipient age (years) | 50.0 (47.0–57.0) | 54.5 (50.0–58.3) | 0.596 |
MELD score | 13.0 (10.0–19.5) | 10.0 (8.3–15.0) | 0.411 |
Cold ischemia time (min) | 66.0 (59.5–104.0) | 96.5 (88.3–105.8) | 0.307 |
Warm ischemia time (min) | 21.0 (17.0–24.0) | 17.5 (11.5–21.3) | 0.469 |
Anhepatic phase time(min) | 29.0 (23.5–49.0) | 26.5 (24.0–31.5) | 0.469 |
Transplantation blood loss (ml) | 3500.0 (1650.0–5200.0) | 1250.0 (1025.0–1425.0) | 0.124 |
Transplantation operative time (min) | 365.0 (332.5–390) | 375.0 (348.8–390.0) | 0.961 |
Hepaticojejunostomy blood loss (ml) | 300.0 (200.0–600.0) | 250.0 (212.5–275.0) | 0.411 |
Hepaticojejunostomy operative time (min) | 250.0 (220.0–282.5) | 255.0 (238.8–266.3) | 0.961 |
Post Transplantation length (month) | 14.5 (10.3–27.0) | 29.3 (24.6–35.6) | 0.185 |
n (%) | n (%) | ||
Gender | 0.097 | ||
Male | 14 (93.3) | 2 (50.0) | |
Female | 1 (6.7) | 2 (50.0) | |
Bile leak | 0.603 | ||
Yes | 7 (46.7) | 1 (25.0) | |
No | 8 (53.3) | 3 (75.0) | |
Bile duct anastomosis orifice | 0.108 | ||
1 | 11 (73.3) | 1 (25.0) | |
2 | 3 (20.0) | 3 (75.0) | |
3 | 1 (6.7) | 0 (0) | |
Type of bile duct anastomosis | 1.000 | ||
D-G | 9 (60.0) | 3 (75.0) | |
D-D | 6 (40.0) | 1 (25.0) | |
T-Tube placement | 0.530 | ||
Yes | 4 (26.7) | 0 (0) | |
No | 11 (73.3) | 4 (100) | |
Hepatic artery complications | 0.530 | ||
Yes | 2 (13.3) | 1 (25.0) | |
No | 13 (86.7) | 3 (75.0) | |
IHD stone | 0.255 | ||
Yes | 9 (60.0) | 4 (100) | |
No | 6 (40.0) | 0 (0) | |
ABO incompatibility | 0.097 | ||
Yes | 1 (6.7) | 2 (50.0) | |
No | 14 (93.3) | 2 (50.0) | |
Rejection | 0.557 | ||
Yes | 4 (26.7) | 2 (50.0) | |
No | 11 (73.3) | 2 (50.0) | |
Survival | 0.530 | ||
Alive | 10 (66.7) | 4 (100.0) | |
Death | 5 (33.3) | 0(0) |